Healthcare DIVE May 24, 2023
Rebecca Pifer

Lawmakers on both sides of the aisle slammed pharmacy benefit managers for allegedly profiting at the expense of patients and taxpayers during a House oversight hearing on Tuesday, the latest congressional inquiry into PBMs.

“They’re having a field day out there getting rich over and over and over again,” said Rep. Kweisi Mfume, D-Md. “It is a sin, it is an abomination, and it is an affront to everything that we hold moral and right in this country.”

Meanwhile, a key PBM lobby was critical of lawmakers for not inviting its members to testify at the hearing.

The Pharmaceutical Care Management Association in a statement denounced the House Oversight and Accountability Committee — one of many government entities currently conducting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?

Share This Article